Results 121 to 130 of about 6,946 (216)

Cardiovascular safety of 5α-reductase inhibitors in people with benign prostatic hyperplasia and type 2 diabetes: a propensity score-matched analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Tu H, Ju C, McGurnaghan SJ, Blackbourn LAK, Scottish Diabetes Research Network Epidemiology Group , Pearson E, Wei L, Andrew R.   +7 more
europepmc   +1 more source

Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis. [PDF]

Int Neurourol J
Niaga KJK, Rinaldi FX, Nathania N, Supinto PA, Lionardi SK, Yo R, Wilyono A, Silalahi PY.   +7 more
europepmc   +1 more source

The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment: A case series study. [PDF]

JAAD Case Rep
Katz A, Dubin C, David KA, Ungar B, Gulati N, Lamb AJ.   +5 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Finasteride and Dutasteride in the Treatment of Benign Prostatic Hyperplasia: A Real-World Retrospective Study. [PDF]

Medicina (Kaunas)
Ratajski J, Ciechan K, Jędrzejczyk P, Kaminski TW, Uciechowski P, Ząbkowski T.   +5 more
europepmc   +1 more source

Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia. [PDF]

Front Pharmacol
Burshtein J, Burshtein A, Schlesinger T.
europepmc   +1 more source

Updates in Treatment for Androgenetic Alopecia. [PDF]

Ann Dermatol
Shin JW, Huh CH.
europepmc   +1 more source

Efficacy and safety of twice- or thrice-weekly dutasteride versus daily finasteride in men with androgenetic alopecia: A randomized, investigator-blinded, active-controlled, parallel-group pilot study. [PDF]

JAAD Int
Sereepanpanich V, Khunkhet S, Rojhirunsakool S, Udompataikul M.   +3 more
europepmc   +1 more source

5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes. [PDF]

NeuroSci
Rodriguez-Cerdeira C.
europepmc   +1 more source

Histopathological characterization of inflammatory interparietal involvement in frontal fibrosing alopecia. [PDF]

Front Med (Lausanne)
Gonzalez Cañete M, Rodríguez-Villa Lario A, Vega Díez D, Vélez Velazquez MD, Ricart Vaya JM, Gómez Zubiaur A.   +5 more
europepmc   +1 more source

SRY mediates male-specific susceptibility to acute liver injury. [PDF]

Cell Commun Signal
Ke MY, Fang Y, Wei SS, Li N, Dai LZ, Zhang XG, Wu RQ, Lyu Y, Zhang XF, Dong J.   +9 more
europepmc   +1 more source